Currently out of the existing stock ratings of Donald Ellis, 32 are a BUY (94.12%), 2 are a HOLD (5.88%).

Donald Ellis

Work Performance Price Targets & Ratings Chart

Analyst Donald Ellis works with a stock forecast success ratio of 50.63% fulfilled within 359.88 days on average.

Donald Ellis’s has documented 67 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CLSD, Clearside Biomedical at 21-Dec-2021.

Wall Street Analyst Donald Ellis

Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for CLSD (CLEARSIDE BIOMEDICAL) at 10/24/2019. The price target of $4 was fulfilled within 448 days with a profit of $3.08 (334.78%) receiving and performance score of 7.47.

Average potential price target upside

ACRS Aclaris Therapeutics AERI Aerie Pharmaceuticals . ENDP Endo International PLC HZNP Horizon Pharma PLC CLSD Clearside Biomedical OCUL Ocular Therapeutix PCRX Pacira Pharmaceuticals SLGL Sol Gel Technologies Ltd

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

3 months 7 days ago

0/2 (0%)

$21.59 (291.36%)

Hold

1.5

3 months 8 days ago

0/4 (0%)

$0.49 (48.51%)

Hold

1

$-0.19 (-15.97%)

2

4 months ago

1/4 (25%)

$0.06 (6.38%)

1

Hold

38

5 months 4 days ago

0/7 (0%)

$23.92 (169.89%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Donald Ellis?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?